New 11-Valent HPV vaccine aims to block more Cancer-Causing viruses
NCT ID NCT05262010
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial is testing an 11-valent HPV vaccine in 13,500 Chinese women aged 18-45. The vaccine targets 11 types of HPV linked to cervical cancer and genital warts. Participants receive three shots over six months and are monitored for several years to see if the vaccine prevents precancerous lesions. The goal is to show the vaccine is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 11-valent recombinant human papillomavirus vaccine
- What this could lead to
- If successful, this vaccine could protect against 11 types of HPV, potentially preventing most cervical cancers and genital warts in women.
- What could go wrong
- This is a large Phase 3 trial, but results are not yet available. The vaccine may not be as effective as hoped, and side effects are possible. It is also only being tested in Chinese women, so results may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hechi Yizhou District Center for Disease Control and Prevention
NOT_YET_RECRUITINGHechi, Guangxi, 546300, China
-
Hezhou Center for Disease Control and Prevention
NOT_YET_RECRUITINGHezhou, Guangxi, 542899, China
-
Lianyuan Center for Disease Control and Prevention
RECRUITINGLianyuan, Hunan, 417100, China
-
Mianyang Youxian District Center for Disease Control and Prevention
NOT_YET_RECRUITINGMianyang, Sichuan, 621000, China
-
Neijiang Shizhong District Center for Disease Control and Prevention
NOT_YET_RECRUITINGNeijiang, Sichuan, 641000, China
-
Qiyang Center for Disease Control and Prevention
RECRUITINGWuxi, Hunan, 426100, China
-
Yongji Center for Disease Control and Prevention
NOT_YET_RECRUITINGYongji, Shanxi, 044500, China
-
Yuanqu Center for Disease Control and Prevention
NOT_YET_RECRUITINGYuncheng, Shanxi, 043700, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily supplement help the body fight off HPV?
- At-Home HPV tests could save lives of women with HIV
- New immune therapy aims to train body to clear HPV
- Could a tiny HPV shot still protect? small study tests lower dose
- New Self-Sampling and digital colposcopy could speed up cervical cancer detection
- Tailored radiation beams aim to outsmart aggressive throat cancer